Named on one round in the feed.
Since 2025-12-16
ROUNDS
1
joined, none as lead
ROUNDS JOINED · USD
$125M
across 1 round
CO-INVESTORS
7
named beside it
Named on one round in the feed.
Since 2025-12-16
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Ambros Therapeutics Innovative medicines for diseases with high unmet medical need, specifically targeting Complex Regional Pain Syndrome Type 1. | Series A Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $125M | 2025-12-16 | [ PART ] |
No sector on record.